• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Myeloma

FDA Logo
June 3, 2013
News Center/Pharmaceutical News

FDA approves Pomalyst for advanced multiple myeloma

[column]The U.S. Food and Drug Administration has approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs. Multiple myeloma is a form of blood cancer that primarily affects older adults and arises from plasma cells

More
FDA Logo
News Center/Pharmaceutical News

FDA approves Pomalyst for advanced multiple myeloma

June 3, 2013

[column]The U.S. Food and Drug Administration has approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after

More
  • The Role of Process and Technology Innovation in Advanced Biopharmaceutical Manufacturing
  • Navigating Regulatory Compliance in the Pharmaceutical Industry
  • How To Effectively Engage With Indonesian Authorities For Medical Device Approval
  • Quotient Sciences Appoints Thierry Van Nieuwenhove as New CEO
  • mRNA Drugs: Pros, Cons, and Prospects

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop